| Product Code: ETC6750260 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Performance Enhancing Drugs Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Performance Enhancing Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 China Performance Enhancing Drugs Market - Industry Life Cycle |
3.4 China Performance Enhancing Drugs Market - Porter's Five Forces |
3.5 China Performance Enhancing Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Performance Enhancing Drugs Market Revenues & Volume Share, By Products, 2021 & 2031F |
3.7 China Performance Enhancing Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Performance Enhancing Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing focus on fitness and sports activities in China |
4.2.2 Growing disposable income leading to higher spending on health and wellness products |
4.2.3 Rise in competitive sports culture driving demand for performance-enhancing drugs |
4.3 Market Restraints |
4.3.1 Stringent regulations and legal restrictions on the use of performance-enhancing drugs |
4.3.2 Negative publicity and health concerns associated with the misuse of such drugs |
5 China Performance Enhancing Drugs Market Trends |
6 China Performance Enhancing Drugs Market, By Types |
6.1 China Performance Enhancing Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Performance Enhancing Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Performance Enhancing Drugs Market Revenues & Volume, By Ergogenic Aids, 2021- 2031F |
6.1.4 China Performance Enhancing Drugs Market Revenues & Volume, By Nootropic, 2021- 2031F |
6.1.5 China Performance Enhancing Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Performance Enhancing Drugs Market, By Products |
6.2.1 Overview and Analysis |
6.2.2 China Performance Enhancing Drugs Market Revenues & Volume, By Pills, 2021- 2031F |
6.2.3 China Performance Enhancing Drugs Market Revenues & Volume, By Injections, 2021- 2031F |
6.2.4 China Performance Enhancing Drugs Market Revenues & Volume, By Patches, 2021- 2031F |
6.2.5 China Performance Enhancing Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Performance Enhancing Drugs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Performance Enhancing Drugs Market Revenues & Volume, By Athletes, 2021- 2031F |
6.3.3 China Performance Enhancing Drugs Market Revenues & Volume, By Body Builders, 2021- 2031F |
6.3.4 China Performance Enhancing Drugs Market Revenues & Volume, By Students, 2021- 2031F |
6.3.5 China Performance Enhancing Drugs Market Revenues & Volume, By Militaries, 2021- 2031F |
6.3.6 China Performance Enhancing Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 China Performance Enhancing Drugs Market Import-Export Trade Statistics |
7.1 China Performance Enhancing Drugs Market Export to Major Countries |
7.2 China Performance Enhancing Drugs Market Imports from Major Countries |
8 China Performance Enhancing Drugs Market Key Performance Indicators |
8.1 Number of sports events and competitions in China |
8.2 Percentage increase in gym memberships and fitness centers |
8.3 Growth in demand for nutritional supplements as an indicator of health and wellness trends in China |
9 China Performance Enhancing Drugs Market - Opportunity Assessment |
9.1 China Performance Enhancing Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Performance Enhancing Drugs Market Opportunity Assessment, By Products, 2021 & 2031F |
9.3 China Performance Enhancing Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Performance Enhancing Drugs Market - Competitive Landscape |
10.1 China Performance Enhancing Drugs Market Revenue Share, By Companies, 2024 |
10.2 China Performance Enhancing Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here